Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Arguing that the Defense Department might have misread evidence and inflicted harm on the company, a federal judge has thrown WuXi AppTec a lifeline as the research and manufacturing services jugge | Arguing that the Defense Department might have misread evidence and inflicted harm on the company, a federal judge has thrown WuXi AppTec a lifeline as the research and manufacturing services juggernaut fights its recent classification by the U.S. government as a Chinese military company.
Federal judge blocks DoD's designation of WuXi AppTec as Chinese military company, citing misreading of corporate ownership. Biosecure Act uncertainty persists: pharma firms dependent on Chinese CDMOs face ongoing regulatory risk despite judicial checks on export restrictions.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

After dodging a layer of U.S. scrutiny thus far, Chinese CDMO WuXi AppTec is back in the government’s crosshairs. The company is…

The major pharmaceutical outsourcing firm argues its addition to the Section 1260H list lacks factual basis and threatens its…

June 11 : WuXi AppTec said on Thursday that it has filed a complaint at the United States District Court for the District of…

Federal judge suspends Pentagon's designation of WuXi AppTec over alleged Chinese military ties, blocking the 1260H listing and…

Chinese biotech company WuXi AppTec has won a temporary reprieve after a federal judge in the United States blocked the Pentagon…

The designation could threaten a key revenue stream for the drug contractor and complicate research, manufacturing and supply…